In the modern era of orthopedics, the shift from cemented to cementless femoral stems represents one of the most significant technological advancements in surgery. As a leading China manufacturer, we understand that "biological fixation" is the key to longevity and patient satisfaction. Cementless hip stems rely on the natural process of osseointegration, where the patient's own bone grows into the micro-porous surface of the implant.
Unlike traditional methods that use bone cement (PMMA), cementless designs utilize high-purity titanium alloys and specialized coatings like Hydroxyapatite (HA). This not only provides immediate primary stability through a precision "press-fit" but also ensures long-term secondary stability, significantly reducing the risk of aseptic loosening—the primary cause of revision surgery.
The global hip replacement market is projected to reach over $10 billion by 2028. Cementless stems now account for over 70% of total hip arthroplasty (THA) procedures in developed nations due to younger, more active patient demographics.
Modern patients demand faster recovery and implants that support "high-demand" activities. Our Ti-alloy cementless stems offer the structural integrity needed for active aging.
Additive manufacturing (3D Printing) allows for complex lattice structures that mimic trabecular bone. We integrate 3D-printed consumables to ensure superior bone ingrowth.
International medical distributors and procurement departments of large hospital networks are increasingly looking for manufacturers that balance uncompromising quality with economic efficiency. As a China-based factory, we address the critical pain points of the global supply chain:
The demand for "Value-Based Healthcare" means providers need implants that prevent costly revision surgeries. Our cementless hip stems are engineered for a "fit-and-forget" outcome, proving their reliability in over 200 hospitals across Sichuan Province and beyond.
Whether it is a primary THA for osteoarthritis or complex revision arthroplasty for bone loss, our product range is versatile. For example, our S-ROM Titanium Alloy Stems are specifically designed for revision cases where femoral geometry is compromised, offering modularity that allows surgeons to customize the fit intraoperatively.
In emerging markets, where orthopedic surgeons are rapidly adopting western clinical protocols, our technical support and instrument sets provide a "complete solution" that lowers the barrier to entry for advanced cementless surgery.
Established in 2015, Shenzhen Weed Medical Apparatus Co., Ltd. has evolved from a local medical device distributor into a high-tech manufacturer specializing in surgical consumables. Our technical department collaborates directly with university professors and frontline clinical staff to bridge the gap between engineering and the operating room.
We are not just a factory; we are an innovation hub. Our business is divided into direct sales and global distribution, covering:
Our reputation is built on the feedback of clinical users. By focusing on the "technological contributions" of our products, we solve common surgical problems like implant subsidence and periprosthetic fractures through improved design geometry.